HHS/OIG Recommends DMERCs Quantify Identified Overpayments For DME
This article was originally published in The Gray Sheet
Executive Summary
Medicare's Durable Medical Equipment Regional Carrier (DMERC) fraud units should track data on the amount of overpayment dollars "collected, written off, or pending" in order to establish the effectiveness of their efforts, the HHS Office of Inspector General recommends in a March 13 report.
You may also be interested in...
Device Firms May Be Held To OIG Pharmaceutical Compliance Standards
The HHS Office of the Inspector General's draft pharmaceutical industry compliance guide has relevance for device manufacturers, and demands their close scrutiny, health lawyers told participants during a recent Food & Drug Law Institute event
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.